Tirzepatide (Tirz) is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist developed for advanced research into metabolic disorders, glucose control, and body weight regulation. By activating both incretin pathways, Tirzepatide has demonstrated strong potential for enhancing insulin secretion, improving insulin sensitivity, and promoting appetite suppression in preclinical models.

Research Applications & Potential Effects:

• Studies on glucose regulation and insulin resistance improvement

• Research into appetite suppression and caloric intake reduction

• Evaluation of dual incretin action in metabolic health

• Preclinical investigation into cardiovascular and lipid profile effects

Supplied as a sterile, lyophilised powder in liquid to ensure maximum stability and purity for controlled laboratory use.

Molecular Formula: C225H348N48O68
Molar Mass: 4813.52 g/mol
Form: Lyophilised powder in liquid
Purity: ≥ 99% (HPLC)
Storage: Store at −20 °C, protect from light
Intended Use: Strictly for research purposes only. Not for human consumption, medical, or veterinary use.
CAS Number: 2023788-19-2